Vaxart (merged with Aviragen Therapeutics)'s Merger

Vaxart (merged with Aviragen Therapeutics) raised a round of funding on February 13, 2018. Investors include Vaxart.

Vaxart has developed a vaccine delivery system that greatly enhances the adaptive immune response to orally delivered antigens. The vaccine system provides a key stimulatory signal (double-stranded RN…

Articles about Vaxart (merged with Aviragen Therapeutics)'s Merger: